Adrenergic Blocking Agents. A Double-Blind Trial in the Treatment of the Eye Signs of Thyroid Disorders.

British Journal of Ophthalmology - United Kingdom
doi 10.1136/bjo.52.8.616
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Efficacy of the LED Red Light Therapy in the Treatment of Temporomandibular Disorders: Double Blind Randomized Controlled Trial

Pain Research and Treatment
NeurologyAnesthesiologyPain Medicine
2019English

Quetiapine Versus Haloperidol in the Treatment of Delirium: A Double-Blind, Randomized, Controlled Trial

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2013English

A Comparison of Beta Adrenergic Blocking Drugs in the Treatment of Hypertension

Postgraduate Medical Journal
Medicine
1974English

Trazodone, a Double Blind Trial for Treatment of Erectile Dysfunction

International Journal of Impotence Research
Urology
1997English

Beta-Adrenergic Blocking Drugs and Thyroid Function.

BMJ
1977English

Risperidone vs Olanzapine in Treatment of Schizophrenia: A Double Blind Clinical Trial

MOJ Addiction Medicine & Therapy
2018English

Aripiprazole for the Treatment of Methamphetamine Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial

Addiction
MedicinePsychiatryMental Health
2013English

Randomised Double Blind Trial of Somatostatin in the Treatment of Massive Upper Gastrointestinal Haemorrhage.

Gut
Gastroenterology
1985English

Failure of Adrenergic and Cholinergic Blocking Agents to Block Ovulation in the Rat

American Journal of Physiology-Legacy Content
1961English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy